DBVT DBV Technologies
- 0.576
- +0.006+0.96%
- 0.550
- -0.026-4.46%
DBV Technologies News
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading; End Week Up Nearly 3%
European equities traded in the US as American depositary receipts were trending higher late Friday morning, rising 0.60 to 1,414.50 on the S&P Europe Select ADR Index. With the gain, the index is poi
DBV Technologies to Participate in Upcoming Investor Conferences
Montrouge, France, May 9, 2024 DBV Technologies to Participate in Upcoming Investor Conferences DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a
DBV Technologies Is Maintained at Buy by HC Wainwright & Co.
DBV Technologies Is Maintained at Buy by HC Wainwright & Co.
DBV Technologies Price Target Cut to $5.00/Share From $10.00 by HC Wainwright & Co.
DBV Technologies Price Target Cut to $5.00/Share From $10.00 by HC Wainwright & Co.
HC Wainwright & Co. Maintains Buy on DBV Technologies, Lowers Price Target to $5
HC Wainwright & Co. analyst Andrew Fein maintains DBV Technologies (NASDAQ:DBVT) with a Buy and lowers the price target from $10 to $5.
DBV Technologies Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/08/2024 639.62% HC Wainwright & Co. $10 → $5 Maintains Buy 02/21/2024 1379.24% HC Wainwright & Co. → $1
Optimistic Buy Rating for DBV Technologies With Viaskin's Market Potential and Regulatory Prospects
Buy Rating Affirmed for DBV Technologies SA Amidst Strong Clinical Progress and Solid Financial Footing
DBV Technologies Q1 EPS $0.28 Beats $(0.21) Estimate, Sales $1.40M Miss $2.27M Estimate
DBV Technologies (NASDAQ:DBVT) reported quarterly earnings of $0.28 per share which beat the analyst consensus estimate of $(0.21) by 233.33 percent. This is a 227.27 percent increase over losses of $
DBV Technologies Posts Wider 1Q Loss, Reports Going Concern Doubts
By Mary de Wet DBV Technologies reported a wider loss in its first quarter and said there is doubt about the company's ability to continue as a going concern. The French biopharmaceutical company ha
DBV Technologies | 10-Q: Quarterly report
DBV Technologies: Available Cash, Cash Equivalents Are Not Projected to Be Sufficient to Support Operating Plan for at Least the Next 12 Mos
DBV Technologies: Available Cash, Cash Equivalents Are Not Projected to Be Sufficient to Support Operating Plan for at Least the Next 12 Mos
DBV Technologies: 'There Is Substantial Doubt Regarding the Company's Ability to Continue as a Going Concern' >DBV.FR
DBV Technologies: 'There Is Substantial Doubt Regarding the Company's Ability to Continue as a Going Concern' >DBV.FR
DBV Technologies 1Q Loss/Shr 28c >DBV.FR
DBV Technologies 1Q Loss/Shr 28c >DBV.FR
DBV Technologies Reports First Quarter 2024 Financial Results and Business Update
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersAllarity Therapeutics (NASDAQ:ALLR) stock moved upwards by 106.6% to $2.83 during Thursday's pre-market session. The market value of their outstanding shares is at $5.5 million. Emergent BioSol
Combined General Meeting of May 16, 2024
Châtillon, France, April 25, 2024 Combined General Meeting of May 16, 2024 Procedures for Obtaining Information and Preparatory Documents for the Combined General Meeting DBV Technologies (Euronext: DBV – ISIN:
European Equities Traded in the US as American Depositary Receipts Jump in Tuesday Trading
European equities traded in the US as American depositary receipts jumped Tuesday morning, advancing 1.31% to 1,362.51 on the S&P Europe Select ADR Index. From continental Europe, the gainers were led
European Equities Traded in the US as American Depositary Receipts Rebound in Monday Trading
After closing out last week more than 2% lower, European equities traded in the US as American depositary receipts rebounded Monday morning, rising 1.09% to 1,340.58 on the S&P Europe Select ADR Index
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down
European equities traded in the US as American depositary receipts were trending higher Friday morning, rising 0.46% to 1,330.20 on the S&P Europe Select ADR Index. Despite the gain, the index remains
Analysis
Price Target
No Data
